HealthGranules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate CapsulesNewsmantraJanuary 31, 2025 by NewsmantraJanuary 31, 20250 Mumbai, 30th January 2025 – Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that...
